Cargando…
POST-DISCHARGE FOLLOW-UP WITH QUALITY OF LIFE ASSESSMENT IN COVID 19 PATIENTS ADMITTED DURING THE COVID 19 PANDEMIC
INTRO: Patients affected with COVID-19 have been reported to have persistent symptoms even months after the acute episode, most commonly fatigue, breathlessness, and symptoms of anxiety and depression. These residual symptoms have been shown to compromise the quality of life and lead to significant...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186960/ http://dx.doi.org/10.1016/j.ijid.2023.04.300 |
_version_ | 1785042660212342784 |
---|---|
author | Syed, B. Ahsan, M. Memon, I. |
author_facet | Syed, B. Ahsan, M. Memon, I. |
author_sort | Syed, B. |
collection | PubMed |
description | INTRO: Patients affected with COVID-19 have been reported to have persistent symptoms even months after the acute episode, most commonly fatigue, breathlessness, and symptoms of anxiety and depression. These residual symptoms have been shown to compromise the quality of life and lead to significant impairment in both the mental and physical health of these patients. METHODS: A prospective observational cohort study was carried out and patients were followed for a month after discharge. Residual symptoms were noted, quality of life (QoL) assessment was done using EQ-5D-5L, and anxiety/depression was evaluated using WHO-SRQ 20 scores. Appropriate statistical tests were applied to compare improvement in QoL and residual symptoms between first and the last visit. FINDINGS: A total of 110 patients were included. Mean age of the patients was 53.7 (SD+/- 13) years. Most common symptoms at 1st follow up were shortness of breath (66%) and fatigue (65%) which reduced in frequency on the last visit to (43%) and (46%) respectively. Significant improvement was seen in SpO2 levels recorded at both visits (p=0.000). An overall improvement in QoL was seen (p=0.000). WHO-SRQ 20 score above 8 was noted in 20% patients and mean score was 5.91. On further categorization into mild, moderate, severe and critical disease on admission, patients showed improvement in symptoms at four weeks irrespective of categories. For QoL assessment, mean utility score showed improvement in all disease categories on the 2nd visit except for patients with mild disease on admission. CONCLUSION: Our study showed a significant improvement in residual symptoms and overall quality of life when followed over a period of time in majority of the patients. Symptoms of anxiety and depression were also not frequent. However, our findings emphasize the need of a multidisciplinary approach towards rehabilitation of COVID-19 patients for earlier improvement in their quality of life. |
format | Online Article Text |
id | pubmed-10186960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101869602023-05-16 POST-DISCHARGE FOLLOW-UP WITH QUALITY OF LIFE ASSESSMENT IN COVID 19 PATIENTS ADMITTED DURING THE COVID 19 PANDEMIC Syed, B. Ahsan, M. Memon, I. Int J Infect Dis Article INTRO: Patients affected with COVID-19 have been reported to have persistent symptoms even months after the acute episode, most commonly fatigue, breathlessness, and symptoms of anxiety and depression. These residual symptoms have been shown to compromise the quality of life and lead to significant impairment in both the mental and physical health of these patients. METHODS: A prospective observational cohort study was carried out and patients were followed for a month after discharge. Residual symptoms were noted, quality of life (QoL) assessment was done using EQ-5D-5L, and anxiety/depression was evaluated using WHO-SRQ 20 scores. Appropriate statistical tests were applied to compare improvement in QoL and residual symptoms between first and the last visit. FINDINGS: A total of 110 patients were included. Mean age of the patients was 53.7 (SD+/- 13) years. Most common symptoms at 1st follow up were shortness of breath (66%) and fatigue (65%) which reduced in frequency on the last visit to (43%) and (46%) respectively. Significant improvement was seen in SpO2 levels recorded at both visits (p=0.000). An overall improvement in QoL was seen (p=0.000). WHO-SRQ 20 score above 8 was noted in 20% patients and mean score was 5.91. On further categorization into mild, moderate, severe and critical disease on admission, patients showed improvement in symptoms at four weeks irrespective of categories. For QoL assessment, mean utility score showed improvement in all disease categories on the 2nd visit except for patients with mild disease on admission. CONCLUSION: Our study showed a significant improvement in residual symptoms and overall quality of life when followed over a period of time in majority of the patients. Symptoms of anxiety and depression were also not frequent. However, our findings emphasize the need of a multidisciplinary approach towards rehabilitation of COVID-19 patients for earlier improvement in their quality of life. Published by Elsevier Ltd. 2023-05 2023-05-16 /pmc/articles/PMC10186960/ http://dx.doi.org/10.1016/j.ijid.2023.04.300 Text en Copyright © 2023 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Syed, B. Ahsan, M. Memon, I. POST-DISCHARGE FOLLOW-UP WITH QUALITY OF LIFE ASSESSMENT IN COVID 19 PATIENTS ADMITTED DURING THE COVID 19 PANDEMIC |
title | POST-DISCHARGE FOLLOW-UP WITH QUALITY OF LIFE ASSESSMENT IN COVID 19 PATIENTS ADMITTED DURING THE COVID 19 PANDEMIC |
title_full | POST-DISCHARGE FOLLOW-UP WITH QUALITY OF LIFE ASSESSMENT IN COVID 19 PATIENTS ADMITTED DURING THE COVID 19 PANDEMIC |
title_fullStr | POST-DISCHARGE FOLLOW-UP WITH QUALITY OF LIFE ASSESSMENT IN COVID 19 PATIENTS ADMITTED DURING THE COVID 19 PANDEMIC |
title_full_unstemmed | POST-DISCHARGE FOLLOW-UP WITH QUALITY OF LIFE ASSESSMENT IN COVID 19 PATIENTS ADMITTED DURING THE COVID 19 PANDEMIC |
title_short | POST-DISCHARGE FOLLOW-UP WITH QUALITY OF LIFE ASSESSMENT IN COVID 19 PATIENTS ADMITTED DURING THE COVID 19 PANDEMIC |
title_sort | post-discharge follow-up with quality of life assessment in covid 19 patients admitted during the covid 19 pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186960/ http://dx.doi.org/10.1016/j.ijid.2023.04.300 |
work_keys_str_mv | AT syedb postdischargefollowupwithqualityoflifeassessmentincovid19patientsadmittedduringthecovid19pandemic AT ahsanm postdischargefollowupwithqualityoflifeassessmentincovid19patientsadmittedduringthecovid19pandemic AT memoni postdischargefollowupwithqualityoflifeassessmentincovid19patientsadmittedduringthecovid19pandemic |